Business Services Industry

Geron Corporation Announces Receipt of $12.5 Million of Proceeds From Exercise of Warrants

Business Wire, Jan 12, 2005

MENLO PARK, Calif. -- Geron Corporation (Nasdaq:GERN) today announced the receipt of gross proceeds of $12.5 million upon the exercise of warrants to purchase approximately 2.0 million shares of common stock. The warrants were issued to institutional investors in connection with the financing announced in November 2004 and had an expiration date of January 11, 2005.

Geron is a biopharmaceutical company focused on developing and commercializing therapeutic and diagnostic products for cancer based on its telomerase technology, and cell-based therapeutics using its human embryonic stem cell technology.

COPYRIGHT 2005 Business Wire
COPYRIGHT 2008 Gale, Cengage Learning

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement

Most Recent Business Articles

Most Recent Business Publications

Most Popular Business Articles

Most Popular Business Publications

Content provided in partnership with Thompson Gale